Viking Global Investors LP Standard Biotools Inc. Transaction History
Viking Global Investors LP
- $25.1 Billion
- Q2 2024
A detailed history of Viking Global Investors LP transactions in Standard Biotools Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 58,651,170 shares of LAB stock, worth $113 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
58,651,170
Previous 58,651,170
-0.0%
Holding current value
$113 Million
Previous $159 Million
34.69%
% of portfolio
0.41%
Previous 0.61%
Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
148Shares Held
269MCall Options Held
422KPut Options Held
40.7K-
Casdin Capital, LLC New York, NY64MShares$123 Million9.8% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$41.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$30.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY12.9MShares$24.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.7MShares$24.3 Million0.2% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $151M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...